Literature DB >> 11173856

Nondisjunction in trisomy 21: origin and mechanisms.

M B Petersen1, M Mikkelsen.   

Abstract

Chromosomal aneuploidy is a fundamental characteristic of the human species. In this review we summarize the knowledge about the origin and mechanisms of nondisjunction in human trisomy 21 that has accumulated during the last decade by using DNA polymorphism analysis. The first molecular correlate of nondisjunction in humans is altered recombination, meiosis I errors being associated with reduced recombination and maternal meiosis II errors with increased recombination between the nondisjoined chromosomes. Thus, virtually all maternal meiotic errors of chromosome 21 seem to be initiated in meiosis I. Advanced maternal age remains the only well documented risk factor for maternal meiotic nondisjunction, but there is, however, still a surprising lack of understanding of the basic mechanisms behind the maternal age effect. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11173856     DOI: 10.1159/000056844

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  13 in total

1.  Variant alleles, triallelic patterns, and point mutations observed in nuclear short tandem repeat typing of populations in Bosnia and Serbia.

Authors:  René L M Huel; Lara Basić; Kamelija Madacki-Todorović; Lejla Smajlović; Izet Eminović; Irfan Berbić; Ana Milos; Thomas J Parsons
Journal:  Croat Med J       Date:  2007-08       Impact factor: 1.351

2.  Down syndrome: parental origin, recombination, and maternal age.

Authors:  Jadranka Vraneković; Ivana Babić Božović; Zorana Grubić; Jasenka Wagner; Dinko Pavlinić; Sophie Dahoun; Frédérique Bena; Vida Culić; Bojana Brajenović-Milić
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-23

Review 3.  Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease.

Authors:  James A Briggs; Elizabeth A Mason; Dmitry A Ovchinnikov; Christine A Wells; Ernst J Wolvetang
Journal:  Stem Cells Transl Med       Date:  2013-02-14       Impact factor: 6.940

4.  Prenatal and Postnatal Therapies for Down's Syndrome and Associated Developmental Anomalies and Degenerative Deficits: A Systematic Review of Guidelines and Trials.

Authors:  Zinnat Hasina; Chi Chiu Wang
Journal:  Front Med (Lausanne)       Date:  2022-07-05

5.  Down Syndrome - Genetics and Cardiogenetics.

Authors:  Vasilica Plaiasu
Journal:  Maedica (Bucur)       Date:  2017-09

6.  Germ-line transmission of trisomy 21: Data from 80 families suggest an implication of grandmaternal age and a high frequency of female-specific trisomy rescue.

Authors:  Natalia V Kovaleva
Journal:  Mol Cytogenet       Date:  2010-03-18       Impact factor: 2.009

7.  Severity of occlusal disharmonies in down syndrome.

Authors:  Danielle Bauer; Carla A Evans; Ellen A Begole; Larry Salzmann
Journal:  Int J Dent       Date:  2012-08-15

8.  Transmission of trisomy decreases with maternal age in mouse models of Down syndrome, mirroring a phenomenon in human Down syndrome mothers.

Authors:  Shani Stern; David Biron; Elisha Moses
Journal:  BMC Genet       Date:  2016-07-11       Impact factor: 2.797

9.  Ophthalmic manifestations of children with Down syndrome in Port Harcourt, Nigeria.

Authors:  Adedayo Omobolanle Adio; Samuel Otabor Wajuihian
Journal:  Clin Ophthalmol       Date:  2012-11-09

10.  Cytogenetic study in children with down syndrome among kosova Albanian population between 2000 and 2010.

Authors:  Selim Kolgeci; Jehona Kolgeci; Mehmedali Azemi; Ruke Shala-Beqiraj; Zafer Gashi; Mentor Sopjani
Journal:  Mater Sociomed       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.